225 related articles for article (PubMed ID: 12874027)
1. Menin associates with FANCD2, a protein involved in repair of DNA damage.
Jin S; Mao H; Schnepp RW; Sykes SM; Silva AC; D'Andrea AD; Hua X
Cancer Res; 2003 Jul; 63(14):4204-10. PubMed ID: 12874027
[TBL] [Abstract][Full Text] [Related]
2. Multiple endocrine neoplasia type 1 interacts with forkhead transcription factor CHES1 in DNA damage response.
Busygina V; Kottemann MC; Scott KL; Plon SE; Bale AE
Cancer Res; 2006 Sep; 66(17):8397-403. PubMed ID: 16951149
[TBL] [Abstract][Full Text] [Related]
3. Role of miR-24 in Multiple Endocrine Neoplasia Type 1: A Potential Target for Molecular Therapy.
Marini F; Brandi ML
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298972
[TBL] [Abstract][Full Text] [Related]
4. Menin is required for optimal processing of the microRNA let-7a.
Gurung B; Muhammad AB; Hua X
J Biol Chem; 2014 Apr; 289(14):9902-8. PubMed ID: 24563463
[TBL] [Abstract][Full Text] [Related]
5. Stable overexpression of MEN1 suppresses tumorigenicity of RAS.
Kim YS; Burns AL; Goldsmith PK; Heppner C; Park SY; Chandrasekharappa SC; Collins FS; Spiegel AM; Marx SJ
Oncogene; 1999 Oct; 18(43):5936-42. PubMed ID: 10557080
[TBL] [Abstract][Full Text] [Related]
6. Molecular and genetic mechanisms of tumorigenesis in multiple endocrine neoplasia type-1.
Guo SS; Sawicki MP
Mol Endocrinol; 2001 Oct; 15(10):1653-64. PubMed ID: 11579199
[TBL] [Abstract][Full Text] [Related]
7. MEN1 in pancreatic endocrine tumors: analysis of gene and protein status in 169 sporadic neoplasms reveals alterations in the vast majority of cases.
Corbo V; Dalai I; Scardoni M; Barbi S; Beghelli S; Bersani S; Albarello L; Doglioni C; Schott C; Capelli P; Chilosi M; Boninsegna L; Becker KF; Falconi M; Scarpa A
Endocr Relat Cancer; 2010 Sep; 17(3):771-83. PubMed ID: 20566584
[TBL] [Abstract][Full Text] [Related]
8. Menin molecular interactions: insights into normal functions and tumorigenesis.
Agarwal SK; Kennedy PA; Scacheri PC; Novotny EA; Hickman AB; Cerrato A; Rice TS; Moore JB; Rao S; Ji Y; Mateo C; Libutti SK; Oliver B; Chandrasekharappa SC; Burns AL; Collins FS; Spiegel AM; Marx SJ
Horm Metab Res; 2005 Jun; 37(6):369-74. PubMed ID: 16001329
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of disease: multiple endocrine neoplasia type 1-relation to chromatin modifications and transcription regulation.
Dreijerink KM; Höppener JW; Timmers HM; Lips CJ
Nat Clin Pract Endocrinol Metab; 2006 Oct; 2(10):562-70. PubMed ID: 17024155
[TBL] [Abstract][Full Text] [Related]
10. Ribozyme-mediated compensatory induction of menin-oncosuppressor function in primary fibroblasts from MEN1 patients.
Luzi E; Marini F; Tognarini I; Carbonell Sala S; Galli G; Falchetti A; Brandi ML
Cancer Gene Ther; 2010 Nov; 17(11):814-25. PubMed ID: 20706287
[TBL] [Abstract][Full Text] [Related]
11. The multiple endocrine neoplasia type 1 gene product, menin, inhibits insulin production in rat insulinoma cells.
Sayo Y; Murao K; Imachi H; Cao WM; Sato M; Dobashi H; Wong NC; Ishida T
Endocrinology; 2002 Jun; 143(6):2437-40. PubMed ID: 12021209
[TBL] [Abstract][Full Text] [Related]
12. Mutation of the MENIN gene in sporadic pancreatic endocrine tumors.
Wang EH; Ebrahimi SA; Wu AY; Kashefi C; Passaro E; Sawicki MP
Cancer Res; 1998 Oct; 58(19):4417-20. PubMed ID: 9766672
[TBL] [Abstract][Full Text] [Related]
13. Multiple endocrine neoplasia type 1: a chromatin writer's block.
Dreijerink KM; Lips CJ; Timmers HT
J Intern Med; 2009 Jul; 266(1):53-9. PubMed ID: 19522825
[TBL] [Abstract][Full Text] [Related]
14. Germline mutation profile of MEN1 in multiple endocrine neoplasia type 1: search for correlation between phenotype and the functional domains of the MEN1 protein.
Wautot V; Vercherat C; Lespinasse J; Chambe B; Lenoir GM; Zhang CX; Porchet N; Cordier M; Béroud C; Calender A
Hum Mutat; 2002 Jul; 20(1):35-47. PubMed ID: 12112656
[TBL] [Abstract][Full Text] [Related]
15. Menin interacting proteins as clues toward the understanding of multiple endocrine neoplasia type 1.
Poisson A; Zablewska B; Gaudray P
Cancer Lett; 2003 Jan; 189(1):1-10. PubMed ID: 12445671
[TBL] [Abstract][Full Text] [Related]
16. Broad tumor spectrum in a mouse model of multiple endocrine neoplasia type 1.
Loffler KA; Biondi CA; Gartside M; Waring P; Stark M; Serewko-Auret MM; Muller HK; Hayward NK; Kay GF
Int J Cancer; 2007 Jan; 120(2):259-67. PubMed ID: 17044021
[TBL] [Abstract][Full Text] [Related]
17. Menin missense mutants associated with multiple endocrine neoplasia type 1 are rapidly degraded via the ubiquitin-proteasome pathway.
Yaguchi H; Ohkura N; Takahashi M; Nagamura Y; Kitabayashi I; Tsukada T
Mol Cell Biol; 2004 Aug; 24(15):6569-80. PubMed ID: 15254225
[TBL] [Abstract][Full Text] [Related]
18. Foxa2, a novel protein partner of the tumour suppressor menin, is deregulated in mouse and human MEN1 glucagonomas.
Bonnavion R; Teinturier R; Gherardi S; Leteurtre E; Yu R; Cordier-Bussat M; Du R; Pattou F; Vantyghem MC; Bertolino P; Lu J; Zhang CX
J Pathol; 2017 May; 242(1):90-101. PubMed ID: 28188614
[TBL] [Abstract][Full Text] [Related]
19. Mutation of tumor suppressor gene Men1 acutely enhances proliferation of pancreatic islet cells.
Schnepp RW; Chen YX; Wang H; Cash T; Silva A; Diehl JA; Brown E; Hua X
Cancer Res; 2006 Jun; 66(11):5707-15. PubMed ID: 16740708
[TBL] [Abstract][Full Text] [Related]
20. Functional studies of the MEN1 gene.
Chandrasekharappa SC; Teh BT
J Intern Med; 2003 Jun; 253(6):606-15. PubMed ID: 12755956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
